Neil L Berinstein - JoVE Visualize

Showing results (11-20 of 40) with videos related to

Pageof 4

Sort By:

Oncoimmunology|May 4, 2018

Increased immune infiltration and chemokine receptor expression in head and neck epithelial tumors after neoadjuvant immunotherapy with the IRX-2 regimenNeil L Berinstein, Michael McNamara, Ariane Nguyen, et al.

Anti-Cancer Drugs|April 25, 2003

Stem-cell transplantation in non-Hodgkin's lymphoma: improving outcomeAlessandro M Gianni, Neil L Berinstein, Paul A S Evans, et al.

Journal for Immunotherapy of Cancer|October 26, 2016

Anti-PD-1 increases the clonality and activity of tumor infiltrating antigen specific T cells induced by a potent immune therapy consisting of vaccine and metronomic cyclophosphamideGenevieve M Weir, Olga Hrytsenko, Tara Quinton, et al.

Oncoimmunology|May 12, 2015

Metronomic cyclophosphamide enhances HPV16E7 peptide vaccine induced antigen-specific and cytotoxic T-cell mediated antitumor immune responseGenevieve M Weir, Olga Hrytsenko, Marianne M Stanford, et al.

Melanoma Research|March 14, 2008

Clinical phase I intratumoral administration of two recombinant ALVAC canarypox viruses expressing human granulocyte-macrophage colony-stimulating factor or interleukin-2: the transgene determines the composition of the inflammatory infiltrateGünther F L Hofbauer, Tobias Baur, Marie-Claude Bonnet, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003

Chronic lymphocytic leukemia-reactive T cells during disease progression and after autologous tumor cell vaccinesElena Gitelson, Caitlin Hammond, Jenny Mena, et al.

Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 15, 2015

Immunostimulatory Activity of the Cytokine-Based Biologic, IRX-2, on Human Papillomavirus-Exposed Langerhans CellsDiane M Da Silva, Andrew W Woodham, Paul H Naylor, et al.

Annals of Hematology|January 14, 2014

Survival of patients with transformed lymphoma in the rituximab eraHany R Guirguis, Matthew C Cheung, Eugenia Piliotis, et al.

Oncotargets and Therapy|July 11, 2018

IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancersGregory T Wolf, Jeffrey S Moyer, Michael J Kaplan, et al.

British Journal of Haematology|February 14, 2002

T-cell analysis in identical twins reveals an impaired anti-follicular lymphoma immune response in the patient but not in the healthy twinElena Gitelson, David Spaner, Rena Buckstein, et al.

Pageof 4

Showing results (11-20 of 40) with videos related to

Sort By:

Pageof 4

Oncoimmunology|May 4, 2018

Increased immune infiltration and chemokine receptor expression in head and neck epithelial tumors after neoadjuvant immunotherapy with the IRX-2 regimenNeil L Berinstein, Michael McNamara, Ariane Nguyen, et al.

Anti-Cancer Drugs|April 25, 2003

Stem-cell transplantation in non-Hodgkin's lymphoma: improving outcomeAlessandro M Gianni, Neil L Berinstein, Paul A S Evans, et al.

Journal for Immunotherapy of Cancer|October 26, 2016

Anti-PD-1 increases the clonality and activity of tumor infiltrating antigen specific T cells induced by a potent immune therapy consisting of vaccine and metronomic cyclophosphamideGenevieve M Weir, Olga Hrytsenko, Tara Quinton, et al.

Oncoimmunology|May 12, 2015

Metronomic cyclophosphamide enhances HPV16E7 peptide vaccine induced antigen-specific and cytotoxic T-cell mediated antitumor immune responseGenevieve M Weir, Olga Hrytsenko, Marianne M Stanford, et al.

Melanoma Research|March 14, 2008

Clinical phase I intratumoral administration of two recombinant ALVAC canarypox viruses expressing human granulocyte-macrophage colony-stimulating factor or interleukin-2: the transgene determines the composition of the inflammatory infiltrateGünther F L Hofbauer, Tobias Baur, Marie-Claude Bonnet, et al.

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 10, 2003

Chronic lymphocytic leukemia-reactive T cells during disease progression and after autologous tumor cell vaccinesElena Gitelson, Caitlin Hammond, Jenny Mena, et al.

Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|December 15, 2015

Immunostimulatory Activity of the Cytokine-Based Biologic, IRX-2, on Human Papillomavirus-Exposed Langerhans CellsDiane M Da Silva, Andrew W Woodham, Paul H Naylor, et al.

Annals of Hematology|January 14, 2014

Survival of patients with transformed lymphoma in the rituximab eraHany R Guirguis, Matthew C Cheung, Eugenia Piliotis, et al.

Oncotargets and Therapy|July 11, 2018

IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancersGregory T Wolf, Jeffrey S Moyer, Michael J Kaplan, et al.

British Journal of Haematology|February 14, 2002

T-cell analysis in identical twins reveals an impaired anti-follicular lymphoma immune response in the patient but not in the healthy twinElena Gitelson, David Spaner, Rena Buckstein, et al.

Pageof 4